ATProto Browser

ATProto Browser

Experimental browser for the Atmosphere

Post

Grove Biopharma signs lease at Fulton Labs - https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs

May 3, 2025, 12:20 PM

Record data

{
  "uri": "at://did:plc:itsfoet44icv62twd5t4kxnx/app.bsky.feed.post/3lobdaanvlm2g",
  "cid": "bafyreihnkmh3ondebuq7bs4pyii5a6dwvfil5helwz4cbw6ry4bojp5rfi",
  "value": {
    "text": "Grove Biopharma signs lease at Fulton Labs - https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs",
        "title": "Grove Biopharma signs lease at Fulton Labs",
        "description": "Trammell Crow Company has signed a lease with Grove Biopharma for their headquarters and research and development (R&D) lab at 400 North Aberdeen in Chicago’s Fulton Market neighborhood. The preclinical biotechnology startup, which previously operated out of Portal Innovation’s Fulton Labs location, announced recently the close of a $30 million Series A financing round and is now moving into its own space within a 17,000-square-foot Science-Ready Lab suite."
      }
    },
    "langs": [
      "en"
    ],
    "facets": [
      {
        "index": {
          "byteEnd": 119,
          "byteStart": 45
        },
        "features": [
          {
            "uri": "https://chicago.urbanize.city/post/grove-biopharma-signs-lease-fulton-labs",
            "$type": "app.bsky.richtext.facet#link"
          }
        ]
      }
    ],
    "createdAt": "2025-05-03T12:20:54.383Z"
  }
}